Absence of Developments. (a) Since December 31, 2023, there has been no Material Adverse Effect. (b) Except as set forth on Schedule 3.5(b), since December 31, 2023, the Company has not taken any action described in Section 5.1 that, if such action had been taken after the date hereof and prior to the Closing without the prior written consent of Buyer, would have violated Section 5.1.
Appears in 7 contracts
Samples: Equity Purchase Agreement (Verano Holdings Corp.), Equity Purchase Agreement (Cannabist Co Holdings Inc.), Equity Purchase Agreement (Verano Holdings Corp.)